Table 4.
Factors | Functions | Mechanisms |
---|---|---|
Oxidized LDL | Reduced cell viability, increased lipid accumulation and upregulated p53 and p21 |
MST1‐ mediated autophagy (Cao et al., 2019) |
Increased ROS Increased ROS Increased ROS and cell death Increased ROS and apoptosis |
Caveolin‐1/NOX2 (Wang et al., 2018a) Lysosomal dysfunction (Ahmad & Leake, 2019) MEK1/ERK/NOX4 (Lee et al., 2010) Inhibited autophagy (Liu et al., 2016) |
|
Increased inflammation | ERK/MAPK/TLR4 (Youk et al., 2021) | |
Palmitate | Increased inflammation | ERK/MAPK/TLR4 (Youk et al., 2021) |
CKIP‐1, casein kinase 2‐interacting protein‐1; ERK, extracellular regulated protein kinase; LDL, low‐density lipoprotein; MAPK, mitogen‐activated protein kinase; MEK1, mitogen‐activated protein kinase 1; MST1, mammalian ste20‐like kinase 1; NOX, NADPH oxidase; REGγ, 11S regulatory particles, 28 kDa proteasome activator, proteasome activator subunit 3; ROS, reactive oxygen species; TLR4, toll‐like receptor 4.